Main
>
ONCOLOGY (**)
>
Bladder Cancer>mUC ***
>
Treatment
>
USA. J. Erdafitinib>>
>
>Has Susceptible FGFR2 or FGFR3>
Genetic Alterations
>Has Susceptible FGFR2 or FGFR3>'s products
This section has no products